Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Siryo S.p.A. is a venture capital firm based in Bari, Italy, focusing on disruptive technologies in materials science. The firm specializes in promoting One-Health, which integrates human and environmental health. Siryo manages a portfolio of seven companies and employs a Venture Studio approach to support its investments.
Siryo invests in innovative technologies within the Food/Health, Biomaterials, and Energy & Environment sectors. The firm targets various investment stages, including Friends & Family, Angel, Seed, and Accelerator/Incubator rounds. Investments primarily focus on Southern Europe, North Africa, and the Middle East, providing both financial and operational support to portfolio companies.
Notable companies in Siryo's portfolio include Siryo T.E.C. S.r.l., Oxoco S.r.l., Votis Postbiotica S.r.l., Oloker Therapeutics S.r.l., Celery S.r.l., EggPlant S.r.l., and Typeone Biomaterials S.r.l..
Submit your pitch through their form at siryo.it or email info@siryo.it with your deck.
Siryo invests across various stages, including Friends & Family, Angel, Accelerator/Incubator, Seed, and Seed+ (Extension).
The firm focuses on the Food/Health, Biomaterials, and Energy & Environment sectors, targeting innovative technologies that promote One-Health.
Siryo employs a Venture Studio approach, providing both financial resources and operational tools to help companies transition from lab innovations to market applications.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.